A skin biopsy can show whether a suspicious spot is cancerous, identify the exact type of rash or skin disorder you have, detect bacterial or fungal infections, and reveal signs of autoimmune diseases. It works by removing a small sample of skin and examining it under a microscope, where a pathologist can see cellular details invisible to the naked eye. What your results reveal depends on why the biopsy was taken and how deep the sample goes.
Skin Cancers and Precancerous Growths
The most common reason for a skin biopsy is to determine whether a mole, sore, or unusual growth is cancerous. The pathologist examines the tissue sample to identify one of three main types of skin cancer. Basal cell carcinoma forms in the lower layer of the outermost skin and is the most common type, typically appearing on the face, head, neck, and arms. Squamous cell carcinoma develops in the upper layer of the skin and is also usually found on sun-exposed areas. Both rarely spread to other parts of the body.
Melanoma is less common but more dangerous because it can spread. When a biopsy confirms melanoma, the pathology report includes specific measurements that determine how serious it is. The most important is Breslow thickness, which measures the distance in millimeters from the skin surface to the deepest point the cancer has reached. Tumors under 1 mm are classified as the earliest stage, while those over 4 mm are the most advanced. The report also notes the mitotic rate, which counts how many cells are actively dividing per square millimeter. Even a single dividing cell per square millimeter is enough to bump a thin melanoma into a higher risk category.
The pathologist also checks whether the cancer reaches the edges of the removed tissue, called the margin status. Clear margins mean no cancer cells were found at the borders, suggesting the entire growth was captured. If margins are positive, further removal is typically needed. For melanoma specifically, the original excision often needs to be widened based on how deep the tumor invaded, sometimes extending down to the muscle layer beneath the fat.
Biopsies also catch precancerous changes like actinic keratosis, rough scaly patches caused by years of sun exposure that can eventually progress to squamous cell carcinoma.
Inflammatory and Autoimmune Conditions
When a rash doesn’t respond to treatment or its cause isn’t clear from appearance alone, a biopsy lets the pathologist see the specific pattern of inflammation in the tissue. These microscopic patterns act like fingerprints for different diseases. Psoriasis, for instance, shows a characteristic thickening of the outer skin layer with elongated finger-like projections extending downward, along with clusters of immune cells in specific locations. Eczema shows a different pattern called spongiotic dermatitis, where fluid accumulates between skin cells, making the tissue look sponge-like under magnification.
Autoimmune blistering diseases like pemphigus and pemphigoid require a biopsy to confirm. Standard microscopy shows where the skin layers are separating, but these conditions often need an additional test called direct immunofluorescence. This technique uses fluorescent dyes to detect immune proteins deposited in the skin, either between skin cells or along the junction where the outer and inner layers of skin meet. The location and type of these immune deposits distinguish one blistering disease from another. Importantly, this test requires a separate sample handled differently from a standard biopsy, since even brief exposure to the usual preservative chemical can destroy the evidence.
Other conditions a biopsy can identify include lichen planus, sarcoidosis, dermatomyositis, and vasculitis, each with its own distinctive pattern of inflammation and cellular damage visible under the microscope.
Infections
A skin biopsy can identify bacterial and fungal infections that are difficult to diagnose from the surface. The pathologist applies special stains to the tissue that make organisms visible. The most commonly used is a PAS stain, which highlights the sugar-rich cell walls of fungi, making them stand out against the surrounding tissue. A modified version of this stain removes a natural sugar called glycogen from the sample first, preventing it from being confused with a fungal organism. A silver-based stain can also reveal fungi but is more technically demanding and results can vary between labs.
Beyond identifying the organism itself, the biopsy shows how the infection is interacting with your tissue: how deep it has penetrated, how your immune system is responding, and whether there is tissue damage that might not be obvious from the surface.
How Biopsy Type Affects What You Learn
The technique your doctor uses determines how much skin is collected and, in turn, what the pathologist can evaluate.
- Shave biopsy removes a thin layer from the surface. It works well for conditions limited to the outermost skin layer, like superficial rashes or non-pigmented growths. It should never be used on a suspected melanoma, because shaving off the top can make it impossible to measure tumor depth or properly stage the cancer.
- Punch biopsy uses a small circular blade (typically 3 to 4 mm wide) to cut through the full thickness of skin down to the fat layer. This provides a complete cross-section of all skin layers, making it useful for rashes, deeper infections, and inflammatory conditions. The wound is small enough that it sometimes heals without stitches and generally leaves less scarring than a shave.
- Excisional biopsy removes the entire lesion plus a surrounding margin of normal tissue, cutting down into the fat beneath the skin. This is the method of choice for large or deep tumors and for any pigmented lesion suspicious for melanoma, because it preserves the full architecture needed for accurate diagnosis and staging.
What the Pathology Report Includes
Your results typically arrive within one to two weeks, though complex cases requiring special stains or additional review can take longer. The report will contain a diagnosis along with a microscopic description of what the pathologist saw. Some of the terminology can be confusing, but a few common terms are worth understanding.
“Atypia” means cells look abnormal in size or shape. This doesn’t automatically mean cancer. Cells can appear atypical from repeated scratching, a healing burn, or a chronic wound, and the pathologist factors in your history to distinguish reactive changes from true precancer or malignancy. “Acanthosis” describes thickening of the outer skin layer, a feature of psoriasis and many other conditions. “Margin status,” as described above, tells you whether abnormal cells extend to the edge of the sample.
Context matters enormously in interpreting results. A biopsy taken from skin that has been recently treated, heavily scratched, or chronically irritated can show inflammation and cellular changes that mimic cancer under the microscope. This is why your doctor provides the pathologist with clinical details, including where the sample came from, what the spot looked like, and any prior treatments. A biopsy taken from the wrong part of a lesion, or from an area with scarring or ulceration, can also obscure the underlying diagnosis. If results are inconclusive, a repeat biopsy from a different area is sometimes needed.
Conditions Beyond the Skin
A skin biopsy sometimes reveals diseases that affect the whole body, not just the skin. Sarcoidosis, an inflammatory condition that can involve the lungs, eyes, and joints, often produces distinctive clusters of immune cells in skin tissue. Dermatomyositis, which causes muscle weakness alongside skin rashes, shows a specific pattern of inflammation at the junction between the outer and inner skin layers. Even certain blood vessel disorders and connective tissue diseases like Ehlers-Danlos syndrome can be identified or supported by what the pathologist finds in a skin sample.
In these cases, the biopsy is one piece of a larger diagnostic picture. The microscopic findings guide your doctor toward the right blood tests, imaging, or specialist referrals to confirm what’s going on beneath the surface.